The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT).
暂无分享,去创建一个
Jan-Jakob Sonke | Peter Remeijer | Tomas Janssen | Abrahim Al-Mamgani | Olga Hamming-Vrieze | J. Sonke | P. Remeijer | A. Al-Mamgani | M. Verheij | T. Janssen | W. Heemsbergen | O. Hamming-Vrieze | A. Navran | Marcel Verheij | Arash Navran | Wilma Heemsbergen | Marcel Jonker | Charlotte Zuur | Michiel van den Brekel | M. Jonker | C. Zuur | M. V. D. van den Brekel
[1] Randall K Ten Haken,et al. Parotid gland function after radiotherapy: the combined michigan and utrecht experience. , 2008, International journal of radiation oncology, biology, physics.
[2] C. R. Leemans,et al. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. , 2014, Oral oncology.
[3] M. Dobelbower,et al. Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer. , 2010, International journal of radiation oncology, biology, physics.
[4] Dong M Shin,et al. Recent advances in head and neck cancer. , 2008, The New England journal of medicine.
[5] F. Feng,et al. Clinical Investigation : Head and Neck Cancer Reducing Xerostomia After Chemo-IMRT for Head-and-Neck Cancer : Beyond Sparing the Parotid Glands , 2012 .
[6] C. Leemans,et al. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] A. Balm,et al. Head and neck squamous cell carcinoma in young patients. , 2013, Oral oncology.
[8] Jan-Jakob Sonke,et al. First clinical experience with a multiple region of interest registration and correction method in radiotherapy of head-and-neck cancer patients. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] V. Manem,et al. Modelling recurrence and second cancer risks induced by proton therapy. , 2018, Mathematical medicine and biology : a journal of the IMA.
[10] L. Livi,et al. Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) , 2018, Clinical and translational radiation oncology.
[11] J. Pignon,et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] M. V. van Herk,et al. Head and Neck Margin Reduction With Adaptive Radiation Therapy: Robustness of Treatment Plans Against Anatomy Changes. , 2016, International journal of radiation oncology, biology, physics.
[13] C. Hansen,et al. Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] Harald Paganetti,et al. A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction , 2008, Physics in medicine and biology.
[15] J. Purdy,et al. Long‐term experience with reduced planning target volume margins and intensity‐modulated radiotherapy with daily image‐guidance for head and neck cancer , 2014, Head & neck.
[16] K. Harrington,et al. Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] P. Remeijer,et al. OC-0355: Which anatomical changes in Head & Neck cancer lead to Repeat CT/planning? , 2017 .
[18] A. Al-Mamgani,et al. Elective unilateral nodal irradiation in head and neck squamous cell carcinoma: A paradigm shift. , 2017, European journal of cancer.
[19] Emma Hall,et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.
[20] A. Al-Mamgani,et al. A prospective evaluation of patient-reported quality-of-life after (chemo)radiation for oropharyngeal cancer: which patients are at risk of significant quality-of-life deterioration? , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[21] Jan-Jakob Sonke,et al. Correction strategies to manage deformations in head-and-neck radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] Quynh-Thu Le,et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] S. Nuyts,et al. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy , 2013, Strahlentherapie und Onkologie.
[24] W. Dörr,et al. Consequential late effects in normal tissues. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] Johannes A Langendijk,et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] Johannes A Langendijk,et al. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[27] L. Peters,et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.